These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7504249)
1. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides. Hatta T; Kim S; Yokoyama S; Takaku H Nucleic Acids Symp Ser; 1993; (29):67-8. PubMed ID: 7504249 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides. Hatta T; Kim SG; Nakashima H; Yamamoto N; Sakamoto K; Yokoyama S; Takaku H FEBS Lett; 1993 Sep; 330(2):161-4. PubMed ID: 7689980 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract. Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925 [TBL] [Abstract][Full Text] [Related]
12. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Gao WY; Han FS; Storm C; Egan W; Cheng YC Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582 [TBL] [Abstract][Full Text] [Related]
13. A phosphorothioate oligonucleotide blocks reverse transcription via an antisense mechanism. Boiziau C; Moreau S; Toulmé JJ FEBS Lett; 1994 Mar; 340(3):236-40. PubMed ID: 7510640 [TBL] [Abstract][Full Text] [Related]
14. Secondary structure in the 3' UTR of EGF and the choice of reverse transcriptases affect the detection of message diversity by RT-PCR. Brooks EM; Sheflin LG; Spaulding SW Biotechniques; 1995 Nov; 19(5):806-12, 814-5. PubMed ID: 8588921 [TBL] [Abstract][Full Text] [Related]
15. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity. Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960 [TBL] [Abstract][Full Text] [Related]
17. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase. Gao HQ; Sarafianos SG; Arnold E; Hughes SH J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369 [TBL] [Abstract][Full Text] [Related]
18. In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription. Bordier B; Hélène C; Barr PJ; Litvak S; Sarih-Cottin L Nucleic Acids Res; 1992 Nov; 20(22):5999-6006. PubMed ID: 1281317 [TBL] [Abstract][Full Text] [Related]
19. Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA. Koppelhus U; Zachar V; Nielsen PE; Liu X; Eugen-Olsen J; Ebbesen P Nucleic Acids Res; 1997 Jun; 25(11):2167-73. PubMed ID: 9153317 [TBL] [Abstract][Full Text] [Related]
20. Selective binding of trisamine-modified phosphorothioate antisense DNA to target mRNA improves antisense activity and reduces toxicity. Matsukura M; Okamoto T; Miike T; Sawai H; Shinozuka K Biochem Biophys Res Commun; 2002 May; 293(5):1341-7. PubMed ID: 12054660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]